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Chromatin remodelingcomplexesareknown tomodify chemicalmarksonhistonesor to induceconformational
changes in thechromatin inorder to regulate transcription.Denovodominantmutations indifferentmembersof
theSWI/SNFchromatin remodelingcomplexhaverecentlybeendescribed in individualswithCoffin–Siris (CSS)
and Nicolaides–Baraitser (NCBRS) syndromes. Using a combination of whole-exome sequencing, NGS-based
sequencing of 23SWI/SNF complex genes, andmolecular karyotyping in 46previously undescribed individuals
with CSS and NCBRS, we identified a de novo 1-bp deletion (c.677delG, p.Gly226Glufs∗53) and a de novomis-
sense mutation (c.914G>T, p.Cys305Phe) in PHF6 in two individuals diagnosed with CSS. PHF6 interacts with
the nucleosome remodeling and deacetylation (NuRD) complex implicating dysfunction of a second chromatin
remodeling complex in the pathogenesis of CSS-like phenotypes. Altogether, we identifiedmutations in 60%of
the studied individuals (28/46), located in the genes ARID1A, ARID1B, SMARCB1, SMARCE1, SMARCA2, and
PHF6.Weshow thatmutations inARID1Bare themaincauseofCSS, accounting for 76%of identifiedmutations.
ARID1B andSMARCB1mutationswere also found in individualswith the initial diagnosis ofNCBRS.These indi-
viduals apparently belong to a small subsetwhodisplay an intermediateCSS/NCBRSphenotype.Our proposed
genotype-phenotype correlations are important for molecular screening strategies.
INTRODUCTION
The transcription of the human genome is an intricately regu-
lated process that relies on many contributing factors. There
are numerous known multiprotein complexes, which act by add-
ition or removal of chemical marks on histones or by induction of
conformational chromatin changes in order to fine-tune the tran-
scriptional control of specific genes in specific cellular contexts
or at defined time points in development. In the past few years,
several of these so-called “chromatin remodeling complexes”
have been implicated in the pathogenesis of developmental dis-
orders. Among these is the SWI/SNF complex, a chromatin re-
modeling complex that mainly functions through nucleosome
mobilization, thereby increasing the accessibility of promoters
to DNA-binding proteins (1). Very recently, mutations in the
genes ARID1A, ARID1B, SMARCA4, SMARCB1 and SMARCE1,
all of them encoding proteins belonging to the SWI/SNF com-
plex, were identified to be causative of Coffin–Siris syndrome
(CSS, MIM 135900) (2,3). Interestingly, truncating mutations
in ARID1B have also been described in individuals with un-
specific intellectual disability (ID) (4). CSS is a rare congenital
disorder that is characterized by a combination of hypoplasia/
aplasia of the fifth digit or finger-/toenail, ID and facial coarse-
ness with a wide mouth with thick, everted upper and lower
lips, a broad nasal bridge and nasal tip, thick eyebrows and long
eyelashes. Additionally, there may be organ malformations,
hirsutism, sparse scalp hair, short stature and microcephaly of
variable degrees (5–7). Mutations in the SWI/SNF complex
memberSMARCA2were described to underlie Nicolaides–Barait-
ser syndrome in 2012 (8). Nicolaides–Baraitser syndrome
(NCBRS, MIM 601358), first described in 1993, is characterized
by severe ID, seizures, short stature, microcephaly, facial coarse-
ness and sparse hair (9). Notably, NCBRS individuals do not
display hypoplasia of digits but a swelling of interphalangeal
joints as a distinctive feature (10).
Using a combination of whole-exome sequencing, NGS-based
sequencing of 23 SWI/SNF complex genes, and molecular karyo-
typing in 46 undescribed individuals with a clinical diagnosis of
either CSS or NCBRS, we add PHF6 as a causative gene for the
CSS phenotypic spectrum and show that mutations in ARID1B
are the main cause of CSS. ARID1B mutations can also be
found in individuals clinically diagnosed with NCBRS, suggest-
ing that these syndromes might represent a phenotypic spectrum
rather than two distinct disorders.
RESULTS
PHF6mutations in female individuals diagnosed with CSS
Whole-exome sequencing was performed in individual K2436.
She presented with mild-to-moderate developmental delay,
hypertrichosis, coarse facial features, a-/hypoplastic fifth
finger- and toenail, and hypoplastic fifth digit and fulfilled the
diagnostic criteria for CSS (Fig. 1A; Tables 2 and 3) (6). No
causative variant was detected in any of the described CSS
genes. Searching for de novo mutations identified a c.914G.T
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substitution in PHF6, a gene located within Xq26.3. Sanger
sequencing confirmed de novo occurrence. The substitution
affects a conserved cysteine at position 305 within the second
PHD finger domain of the protein (p.Cys305Phe; Fig. 1B and
C, Table 1), and is predicted to be probably damaging with
a score of 0.997 by PolyPhen (http://genetics.bwh.harvard.
edu/pph2/).
We screened additional nine female and nine male individuals
with typical clinical findings of CSS who were negative for
mutations within the described SWI/SNF complex genes for
Figure 1.Phenotype of females withPHF6mutation. (A)Individual K2436 at the age of 12 months with sparse hair, pointed eyebrows with synophrys, long philtrum,
thin upper and thick lower vermillion border. Hypoplasia of the fifth fingernail, short toes with hypoplastic fifth toenail. (B) Electropherogram of thePHF6missense
mutation identified in individual K2436 compared to wildtype. (C) Schematic representation of the PHF6 protein; the p.Cys305Phe mutation is located within the
second PHD finger domain. (D) Individual K2570 at the age of 2 and 3 years with full eyebrows, synophrys, short philtrum and full lips. Brachytelephalangy and
hypoplastic nails of all fingers as well as brachydactyly of toes and hypoplastic fifth toenail. (E)Electropherogram of the PHF6 frameshift mutation identified in in-
dividual K2570 compared with wildtype. (F)Schematic representation of the PHF6 protein; the p.Gly226Glufs∗53 mutation is 13 amino acid upstream of the second
PHD finger domain.
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mutations in PHF6 and could identify a de novo truncating mu-
tation (c.677delG; p.Gly226Glufs∗53) in individual K2570
(Fig. 1D–F). For one remaining patient (K2707), no DNA was
available for PHF6 sequencing.
Mutational spectrum of the SWI/SNF complex
Whole-exome sequencing in three severely affected (K2426,
K2437, K2442) and two mildly affected individuals with CSS
(K2434, K2435) revealed causative mutations in four of them:
truncating mutations in ARID1A (K2435; Fig. 2A–C) and
ARID1B (K2434) and missense mutations in SMARCB1 (K2426;
Fig. 2D–F) and SMARCE1 (K2442; Fig. 2G–I) (Table 1). The
mutant allele in the ARID1A mutation carrier was detected in a
lower proportion than the wild-type allele, indicating the presence
of somatic mosaicism in the individual (Fig. 2B). Initially, we
missed the truncating mutation in ARID1B in individual K2437
due to insufficient coverage of exon 1 of the ARID1B gene, but
identified the mutation later by Haloplex enrichment followed by
next-generation sequencing. Parental DNA was finally available
for all five affected individuals and the mutations were proven to
be de novo.
The de novomissense mutation p.Arg374Gln in SMARCB1 is
located within exon 9 of the gene and leads to the substitution of
an evolutionary highly conserved amino acid in close proximity
of the sucrose non-fermenting domain 5 (SNF5) of the protein,
likely affecting domain structure (Fig. 2E and F). All seven
mutations within this gene previously described in individuals
with a CSS phenotype are located in exons 8 and 9 of the
SMARCB1 gene (3,11). In addition, PolyPhen (http://genetics.
bwh.harvard.edu/pph2/) predicts this variant to be probably
damaging with a score of 0.998. The de novo SMARCE1 mis-
sense mutation p.Tyr73Ser in individual K2442 is the second
mutation described in this gene, so far. It affects the same
highly conserved amino acid at position 73 within the high mo-
bility domain (HMG box) of the protein as the mutation
described by Tsurusaki et al.(3), but causes a change of tyrosine
to serine instead to cysteine (2 Fig. 2H and I). PolyPhen (http://
genetics.bwh.harvard.edu/pph2/) predicts this change to be prob-
ably damaging with a score of 0.990.
Using massive parallel sequencing of 23 genes enriched by the
Haloplex technology followed by next-generation sequencing,
we found 12 putatively pathogenic sequence variants in genes
associated with the SWI/SNF complex in 13 of 32 individuals
(41%) with a diagnosis of CSS (Table 1, Supplementary Mater-
ial, Fig. S6). All of the identified mutations were novel loss-of-
function mutations inARID1B, either base substitutions or small
insertions/deletions that lead immediately or after a frame-shift
to premature stop codons.Using the Pindel program (12) in order
to detect larger insertions/deletions, we identified a 19-bp inser-
tion in ARID1B in one individual. Parental DNA was available
for 10 individuals with a truncating ARID1B mutation and in
these individuals, the mutations were proven to be de novo.
The p.Trp2014∗ in exon 20 was found twice and the p.Arg750∗
identified in an individual from the discovery cohort was found
in an additional individual. One putative missense mutation in
ARID1A (c.358C.T, p.P120S) was found in an individual with
CSS for whom no parental DNA was available. However, this
Table 1. Overview of identified mutations
Individual Referral diagnosis Gene Exon cDNA Protein Inheritance
K2570 CSS PHF6 7 c.677delG p.Gly226Glufs∗53 De novo
K2436∗ CSS PHF6 9 c.914G.T p.Cys305Phe De novo
K2437∗ CSS ARID1B 1 c.1540dupC p.Gln514Profs∗21 De novo
K2574 CSS ARID1B 4 c.1808dupG p.Ser603Argfs∗50 De novo
K2434∗ CSS ARID1B 6 c.2248C.T p.Arg750∗ De novo
K2441 CSS ARID1B 6 c.2248C.T p.Arg750∗ De novo
K2474 CSS ARID1B 9 c.2692C.T p.Gln898∗ De novo
K2471 CSS ARID1B 9 c.2723delC p.Pro908Hisfs∗6 De novo
K2445 CSS ARID1B 18 c.4216_4217insTGCTGCTGCTCCTACTCGG p.Gln1406Leufs∗59 De novo
K2444 CSS ARID1B 18 c.4770_4771delinsG p.Gln1591Argfs∗23 De novo
K2439 CSS ARID1B 20 c.5071delC p.Leu1691∗ n.a.
K2432 CSS ARID1B 20 c.5457G.A p.Trp1819∗ n.a.
K2578 CSS ARID1B 20 c.6041G.A p.Trp2014∗ n.a.
K2583 CSS ARID1B 20 c.6041G.A p.Trp2014∗ n.a.
K2443 CSS ARID1B 20 c.6382C.T p.Arg2128∗ De novo
K2693 CSS ARID1B 20 c.6439dupA p.Arg2147Lysfs∗45 De novo
K2428 CSS ARID1B arr[hg19] 6q25.3(157,402,040–157,460,542)x1 De novo
K2438 CSS ARID1B arr[hg19] 6q25.3(156,960,439–158,889,653)x1 De novo
K2435∗ CSS ARID1A 20 c.5965C.T p.Arg1989∗ De novo
K2426∗ CSS SMARCB1 9 c.1121G.A p.Arg374Gln De novo
K2442∗ CSS SMARCE1 5 c.218A.C p.Tyr73Ser De novo
K2587 NCBRS ARID1B 4 c.1871delC p.Pro624Hisfs∗44 De novo
K2586 NCBRS ARID1B 12 c.3430C.T p.Gln1144∗ n.a.
K2705 NCBRS ARID1B 14 c.3586dupC p.Gln1196Profs∗14 De novo
K2588 NCBRS SMARCB1 8 c.1096C.T p.Arg366Cys De novo
K2703 NCBRS SMARCA2 18 c.2554G.A p.Glu852Lys De novo
K2704 NCBRS SMARCA2 18 c.2639C.T p.Thr880Ile De novo
K2706 NCBRS SMARCA2 18 c.2564G.A p.Arg855Gln De novo
∗, Discovery cohort (exome); n.a, parental samples unavailable; CSS ¼ Coffin–Siris syndrome; NCBRS, Nicolaides–Baraitser syndrome
5124 Human Molecular Genetics, 2013, Vol. 22, No. 25
variant is predicted to be benign on PolyPhen (http://genetics.
bwh.harvard.edu/pph2/) and lies within a non-conserved region.
We therefore assume this variant to be likely non-pathogenic.
No pathogenic mutations were found in any of the candidate
genes of the SWI/SNF complex that were included in the gene
panel. We identified a missense variant in CBL, SMARCD2
and SMARCC1, respectively, in three individuals with CSS,
which were predicted to be damaging by PolyPhen (http://
genetics.bwh.harvard.edu/pph2/) and, except for one, were not
annotated in databases of human variation [Exome Variant
Figure 2.Clinical findings of CSS individuals withARID1A, SMARCB1 and SMARCE1mutations. (A) Individual K2435 with low frontal hairline, thick and arched
eyebrows, ptosis, low-set ears, thin upper and full lower vermillion border. Brachytelephalangy with mild nail hypoplasia of all fingers and toes. (B) Electropherogram
of theARID1Amutation identified in individual K2435. (C) Schematic representation of the ARID1A protein; the p.Arg1989∗ mutation is located between two LXXL
motifs. (D) Individual K2426 with sparse hair, hypertelorism, downward slanting palpebral fissures, short nose with anteverted nares, large mouth and low-set ears,
nearly absent fifth fingernail and hypoplasia of toenails III and V. (E) Electropherogram of the SMARCB1 mutation identified in individual K2426 compared with
wild type. (F) Schematic representation of the SMARCB1 protein; the p.Arg374Gln mutation is located two amino acids downstream of the predicted SNF5
domain. (G) Individual K2442 with sparse hair, full eyebrows, broad nose, thin upper and full lower vermillion border, aplasia of the fifth fingernail and dystrophy
of all toenails. (H) Electropherogram of the SMARCE1 mutation identified in individual K2442 compared with wild type. (I) Schematic representation of the
SMARCE1 protein; the p.Tyr73Ser mutation is located within the HMG box domain.
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Server (http://evs.gs.washington.edu/EVS/), 1000 genomes
(http://www.1000genomes.org/), dbSNP (http://www.ncbi.nlm.
nih.gov/projects/SNP/)]. All of these variants were inherited
from a healthy parent and were thus estimated to be not causative.
However, we cannot completely exclude a causative role of these
variants, for example as one inherited pathogenic allele in digenic
inheritance.
Molecular karyotyping revealed deletions of the ARID1B
gene in two individuals (K2428, K2438). In individual K2428,
a partial ARID1B intragenic deletion of 58.5 kb comprising
only exons 6–8 of the gene was identified. The deletion was con-
firmed and determined to be de novo by real-time polymerase
chain reaction (PCR) (data not shown). Individual K2438
carries a larger deletion containing at least seven annotated
genes: ARID1B, ZDHHC14, SNX9, SYNJ2, SERAC1, GTF2H5
and TULP4 (Table 1).
ARID1Bmutations in individuals diagnosed with NCBRS
We examined nine individuals with a tentative diagnosis of
NCBRS (Supplementary Material, Tables S1 and S2). In three
of them (33%), we identified a missense mutation in SMARCA2
(Table 1; Supplementary Material, Fig. S4), of which one
(K2704 with the c.2639C.T mutation) was novel and proven
to be de novo. The other two mutations were previously described
in individuals with NCBRS and occurred de novo in individuals
K2703 and K2704 and therefore, were assumed to be pathogenic
(8). Interestingly, all SMARCA2 missense mutations identified
here are located in exon 18. We found mutations in ARID1B in
three of the six remaining NCBRS individuals (50%). All of the
ARID1Bmutations were truncating (Table 1; Supplementary Ma-
terial, Fig. S6), for two of them parental DNA was available for
testing (K2703, K2706) and both mutations occurred de novo.
Additionally, we identified one de novo missense variant,
c.1096C.T, in exon 9 of SMARCB1 in an individual with
NCBRS (K2588), reclassified as CSS. The putative mutation is
not annotated in any database of human genomic variation,
also including dbSNP (http://www.ncbi.nlm.nih.gov/projects/
SNP/) and the Exome Variant Server (http://evs.gs.wa
shington.edu/EVS/) and is predicted to be probably damaging
with a PolyPhen (http://genetics.bwh.harvard.edu/pph2/) score
of 1.0. The mutation substitutes the highly conserved arginine
at position 366 within the SNF5 domain with cysteine
(p.Arg366Cys; Fig. 2, Table 1).
DISCUSSION
The combination of whole-exome sequencing, NGS-based se-
quencing of SWI/SNF complex genes and molecular karyotyp-
ing identified causative dominant mutations in 60% (28/46) of
the previously undescribed individuals studied here with a clin-
ical diagnosis of either CSS or NCBRS.
PHF6mutations in females lead to CSS phenotype
We identified de novo mutations in the X chromosomal gene
PHF6 in two female individuals with a convincing CSS pheno-
type (Table 1; Fig. 1). The 1-bp deletion c.677delG is predicted
to cause a frame-shift and premature termination of the protein
(p.Gly226Glufs∗53), resulting in the loss of the second
PHD-like zinc finger domain of the protein (Fig. 1F). This alter-
ation most likely results in a loss-of-function of the protein, sug-
gesting haploinsufficiency as the disease-causing mechanism.
The other individual carries the de novo c.914G.T mutation,
which affects a highly conserved cysteine within the second
PHD-like zinc finger domain (p.Cys305Phe) providing addition-
al evidence for the functional importance of this domain in PHF6
(Fig. 1C). It is of interest to note that mutations inPHF6have been
previously reported in individuals with Borjeson-Forssman-
Lehmann syndrome (BFLS, MIM 301900). The phenotype is
well known in male individuals (13), but has been described
only twice in females (14,15). The female phenotype in our
two individuals in early infancy is clinically indistinguishable
from CSS with ID, coarse facial features, thick and arched eye-
brows with synophrys, large mouth with thick lower vermillion
border, hypoplasia of distal phalanges, body hirsutism, sparse
scalp hair and nail hypoplasia (Fig. 1). As the phenotypic spec-
trum of CSS is wide—especially in patients withARID1Bmuta-
tions—there is no specific clinical sign in early childhood, which
helps to clinically separate both conditions. More characteristic
phenotypic aspects of BFLS may not be evident in early child-
hood, but occur only later in adolescence or adulthood. Notably,
both female individuals described here fulfilled the diagnostic
criteria for CSS at the time of clinical evaluation.
PHF6 encodes the plant homeodomain (PHD) finger protein 6
(PHF6), expressed in the developing brain as well as in other em-
bryonic tissues (16). Both identified mutations affect the second
PHD-like zinc finger domain of the protein. This domain can dir-
ectly interact with modified histones and is a common structure
of chromatin remodeling proteins. Although no direct inter-
action of PHF6 with SWI/SNF complex proteins has been
described, the phenotypic presentation in individuals with
PHF6 mutations suggests a functional link between PHF6 and
the SWI/SNF complex and a common pathogenic pathway. It
is well established that PHF6 interacts with the nucleosome re-
modeling and deacetylation (NuRD) complex implicated in
chromatin remodeling (17). The NuRD complex is one of the
four major types of ATP-dependent chromatin remodelers (18)
and has similar functions as the SWI/SNF complex in transcrip-
tional regulation through covalent histone modification during
development. It will be an interesting task for future studies to
identify the set of genes transcriptionally altered due to muta-
tions in PHF6 and the SWI/SNF complex genes ARID1B,
ARID1A, SMARCE1, SMARCB1 and SMARCA2. It wouldn’t
be surprising if these would be shown to converge on the same
physiological pathways, demonstrating a common molecular
pathogenesis of the SWI/SNF and PHF6-related disorders (19).
Mutations in SMARCE1 and SMARCB1 lead to severe CSS
So far, only one individual with a CSS-like phenotype and a mis-
sense mutation in SMARCE1 (p.Tyr73Cys) has been published
(3,20). Here, we describe the second individual with a de novo
missense mutation affecting the same amino acid (p.Tyr73Ser)
within the conserved high mobility domain (Fig. 2G–I), who
displays typical findings of CSS. The affected individuals have
severe ID (2/2), the typical craniofacial gestalt (2/2), hypertri-
chosis (1/2), and hypoplastic or absent fifth finger- and toenails
associated with hypoplasia of other nails (2/2). In addition,
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they are small for gestational age (2/2), have postnatal short
stature (2/2) and severe microcephaly (2/2), complex congenital
heart defects (2/2), feeding difficulties (2/2) and seizures (1/2).
The hands of the individual described here were characterized
by long and slender fingers with hypoplasia, especially of the
second and aplasia of the fifth fingernails. All toenails were dys-
trophic and hypoplastic (Fig. 2G). The hands and feet were very
similar to those of the individual published by Kosho et al. (20).
This might help to clinically distinguish individuals eligible for
SMARCE1 testing. Loss-of-function mutations in SMARCE1
cause isolated autosomal dominant multiple-spinal-meningioma
disease (21), which was not noted in both individuals with
SMARCE1 mutation.
Exome sequencing in CSS individuals detected a single muta-
tion in SMARCB1 in a severely affected individual. Truncating
mutations in SMARCB1 have been identified in schwannomato-
sis (22). Only seven individuals with CSS and one individual
with a Kleefstra syndrome-like phenotype with non-truncating
SMARCB1 mutations have yet been described (3,20,23). We
here describe two additional SMARCB1 mutations, one in an in-
dividual with CSS and one in an individual initially classified as
NCBRS (retrospectively reclassified as CSS). These nine
SMARCB1mutations (p.Arg377His (3), p.Lys364del in six indi-
viduals (3,11), p.Arg374Gln and p.Arg366Cys), are all located
within exons 8 and 9 of the gene. These exons encode for the
highly conserved sucrose/non-fermenting domain 5 (SNF5) of
the protein. The phenotype of the individual with Kleefstra-like
syndrome is different from the individuals with CSS with
midface hypoplasia, upward slanting palpebral fissures and
tongue protrusion, and might be explained by the different loca-
tion and functional consequence of the mutation located close to
the N-terminal part of the protein. Thus, mutations at different
locations within the SMARCB1 gene might lead to syndromic
ID different from CSS.
In total, nine individuals with CSS with SMARCB1mutations
are known. They present with developmental delay (7/7), the
typical craniofacial gestalt (7/7), hypertrichosis (5/7) and hypo-
plastic or absent fifth finger- and toenails associated with hypo-
plasia of other nails (7/7). In addition, they are small for
gestational age (3/7), have postnatal short stature (7/7) and
microcephaly (6/7), congenital heart defects (3/7), small cere-
bellum (2/7), abnormal corpus callosum (4/5), diaphragmatic
hernia (1/7), scoliosis (4/6), hearing impairment (5/5), feeding
difficulties (7/7) and seizures (4/6).
ARID1B is the major gene for CSS and associated
with a milder phenotype
In 32 individuals with CSS, a mutational screening was per-
formed using Haloplex enrichment and NGS sequencing. Inter-
estingly, only ARID1B mutations were identified in this cohort
(13/32), which contained predominantly milder CSS pheno-
types. In total, 16 mutations in ARID1B could be identified, in-
cluding those detected by exome sequence and array analysis.
Causative mutations in ARID1B were exclusively loss-of-func-
tion mutations (Table 1). We therefore suspect that only muta-
tions leading to ARID1B haploinsufficiency cause a clinical
phenotype. The phenotype of theARID1B group is characterized
by mild-to-moderate ID (16/16), a facial gestalt reminiscent of
CSS (16/16) (Fig. 3), hypertrichosis (13/15) and hypoplastic,
hardly ever absent fifth finger- and toenails (10/15) (Supplemen-
tary Material, Fig. S1). In addition, they are seldom small for ges-
tational age (1/16) or have postnatal short stature (4/15) or
microcephaly (2/16). Associated clinical anomalies, e.g. con-
genital heart defects (5/14), small cerebellum (0/14), abnormal
corpus callosum (5/14), diaphragmatic hernia (0/16), scoliosis
(2/13), hearing impairment (1/13), feeding difficulties (10/14)
and seizures (4/16) were infrequently reported (specific clinical
data were not available for every clinical sign).
Up to now, 64 individuals with CSS and ARID1B mutations
have been published (including the individuals studied here)
who represent the more severe end of the clinical spectrum of
the ARID1B associated phenotype. In addition, Hoyer et al.
reported on eight individuals with unspecific ID caused by
ARID1B mutations, representing the mild end of the spectrum
(4). Currently, we do not know whyARID1Bmutations are asso-
ciated with a milder phenotype compared to individuals carrying
SMARCB1 or SMARCE1mutations. Different functional conse-
quences on the SWI/SNF complex by ARID1B haploinsuffi-
ciency and SMARCB1/SMARCE1 missense mutations, which
might exert a dominant-negative effect on other complex pro-
teins, could explain the differences in the clinical phenotypes.
Intermediate CSS/NCBRS phenotypes make
clinical distinction difficult
In addition to the group of individuals with clinically well-
defined CSS, we included a clinically less characterized cohort
of nine individuals with tentative diagnosis of NCBRS in our
study. As frequently observed in a routine clinical setting, indi-
viduals were referred to us with the clinical diagnosis of NCBRS,
but no photographs and detailed clinical data were available.
Screening of this cohort for mutations revealed three missense
mutations in the primary NCBRS gene SMARCA2 and, interest-
ingly, three truncating mutations in ARID1B and one missense
mutation in SMARCB1 (Table 1). In the remaining two indivi-
duals, no mutation within the SWI/SNF complex was identified
pointing toward further genetic heterogeneity in NCBRS.
Clinical data and most photographs were finally obtained.
These three individuals with SMARCA2 mutations presented
with a NCBRS phenotype consisting of sparse hair, short
stature, seizures and prominent joints. Detailed clinical evaluation
of the remaining individuals resulted in reclassification of the
ARID1B/SMARCB1 mutation carriers to the CSS phenotypic
spectrum. The facial gestalt, especially in early childhood, may
be very similar in both entities and does not allow discrimination
between CSS and NCBRS. Sparse scalp hair was reported in both
entities. The most distinguishing features are the hands and feet:
Individuals with NCBRS do not manifest hypo- or aplasia of
fifth finger- or toenail but swelling of interphalangeal joints. Tsur-
usaki et al. described one individual with a SMARCA2 mutation
who was previously diagnosed with CSS and reclassified as
NCBRS (3,11), also demonstrating the described diagnostic
dilemma. Thus, a small subset of individuals displays an inter-
mediate CSS/NCBRS phenotype. Molecular testing is essential
to establish the correct diagnosis in these individuals.
In summary, the molecular and clinical analyses of 46 unde-
scribed individuals with either CSS or NCBRS presented here
expand the molecular and clinical spectrum of these disorders
and underscore the phenotypic and pathogenetic overlap.
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Further studies will be needed to elucidate the underlying mo-
lecular pathogenesis in more detail and to shed light on the spe-
cific developmental mechanisms controlled by the relevant
chromatin remodeling complexes.
MATERIALS AND METHODS
Subjects
Individuals with CSS or NCBRS and their parents were clinical-
ly assessed by experienced clinical geneticists. Clinical informa-
tion pertinent to the diagnosis was provided by the parents or
legal guardians for minors and by the evaluating authors.
Detailed clinical data were evaluated by the authors (D.W.,
Y.A., H.K., B.A., K.B., A.C., K.Ch., O.C., J.C.C., K.D., N.E.,
B.G., T.O.G., M.K.-W., E.G.-N., J.H., G.H., E.K., P.O¨.S.-K.,
V.L.-G., S.L., F.O¨., A.Ra., S.T., G.E.U., C.Z., B.W.) and photo-
graphs of the face, hands and feet were available for all 37 indi-
viduals with the diagnosis CSS. For the nine individuals with a
tentative diagnosis of NCBRS detailed clinical data were also
obtained by the evaluating authors (M.T.D., E.G.-N., F.M.,
A.M., M.M.D., G.M., F.M.-P., A.Re., C.V., R.V.), but photo-
graphs and permission to publish them were limited. Detailed
clinical data are listed in Tables 2 and 3 and Supplementary
Figure 3. Craniofacial phenotype of individuals with ARID1B mutation. (A) Upper row from left to right: Individuals K2574, K2434, K2441, K2474 and K2471.
Lower row from left to right: Individuals K2445, K2578, K2443, K2693 and K2428. (B) Schematic view of the ARID1B protein, all coding exons, and localization
of identified ARID1B mutations. The mutations detected in CSS individuals are shown in black, and mutations identified in NCBRS individuals are depicted in red.
Mutations marked with an asterisk were identified in two individuals.
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Table 2. Clinical findings of mutation-positive CSS patients (part I)
K2436 K2570 K2437 K2574 K2434 K2441 K2474 K2471 K2445 K2444 K2439
Gene/mutation PHF6/c.914G.T PHF6/c.677delG ARID1B/
c.1540dupC
ARID1B/
c.1808dupG
ARID1B/
c.2248C.T
ARID1B/
c.2248C.T
ARID1B/
c.2692C.T
ARID1B/
c.2723delC
ARID1B/
c.4216_
4217ins19bp
ARID1B/
c.4770_
4771delinsG
ARID1B/
c.5071delC
Age at diagnosis
(month)
33 96 30 n.r. n.r. 48 84 1 15 36 36
Gender f f f f m m m m f f f
consanguinity in
parents
2 2 2 2 + 2 2 2 + 2 2
Age of mother at birth
(year)
37 35 26 28 29 38 24 26 22 39 n.r.
Age of father at birth
(year)
35 37 31 38 n.r. 44 38 28 29 42 n.r.
ID + + + + + + ++ + + + +
Sat/walked
independently
(month)
.12/30 n.r./18 n.r./27 n.r./ 20 15/24 11/28 20/ 60 10/24 9/2 12 / 30 n.r./21
First words (month) .36 13 36 n.r. 2 48 72 23 2 30 36
Hypotonia + 2 + + + n.r. + + + 2 +
Seizures (year) 2 2 2 2 + 2 2 + 2 2 2
Vision problem 2 Nystagmus,
strabismus
n.r. 2 2 n.r. 2 Strabismus, suspected
optical atrophy
2 Nystagmus,
strabismus
2
Hearing loss 2 2 n.r. 2 2 2 n.r. 2 mild (left ear) 2 n.r.
Frequent infections +/2 cystitis 2 + 2 + 2 2 + 2 2 2
Feeding problems 2 + + + + 2 2 + + + +
Behavioural anomalies +/2 Anxiety friendly, quiet,
easily distracted,
shy
2 2 2 + Aggressive behaviour 2 2 2
Birth (weeks) 39 38 38 39 40 40 38 37 40 38 41
weight [g]/[SD] 3220/20.5 2900/20.7 2440/21.74 2800/21.3 2500/22.5 3.025/20.94 3050/20.6 3200/0.22 3000/21.1 3200/0.1 3700/0.3
length [cm]/[SD] 50/20.3 49/20.7 48/21.04 48/21.4 n.r. 48.6/21.7 n.r. 49/20.5 50/20.8 n.r. 53/0.4
OFC [cm/SD] 35/0.3 33,5/20.6 32/20.23 34/20.5 n.r. 37/1.34 n.r. 35/0.4 n.r. n.r. 37/1.4
Age at examination
(years)
10 5/6 9 11/12 12 n.r. 6 1/2 6 2/12 7 8 3/4 1 3/12 3 3
Height (cm)/(SD) 148.5/1.2 148/1.7 149/20.27 160/0 117/20.1 114.5/20.67 107/23.2 130/20.88 77/0.54 93/20.8 n.r.
OFC (cm/SD) 51/20.9 54/1.4 52.4/20.41 53,5/0 53/0.5 54/ 1.52 51/21.2 56/2.1 46/0.15 49/20.4 51/1.2
Craniofacial anomalies
Coarse face + + + ++ + + + + + 2 +
Low frontal hairline 2 + + + + + + + + 2 +
Synophrys + + 2 + 2 2 + + + 2 2
Thick eyebrows +, arched + + + + + + + + + +
Long eyelashes 2 2 + + + + + + + + 2
Ptosis 2 2 2 + + 2 2 2 + 2 2
Narrow palpebral
fissures
2 2 2 2 2 2 + + 2 2 2
Flat nasal bridge 2 + 2 + + 2 + 2 + + 2
Broad nose 2 + 2 + + + + + + 2 +
Upturned nasal tip + 2 2 2 2 2 2 2 2 + 2
Thick, anteverted
alae nasi
+ 2 + + 2 + + + + + +
Large mouth + + + ++ + + + + + + +
Thin upper
vermillion
+ 2 2 + + n.r. + + + 2 +
Thick lower vermillion + + + ++ + + + + + 2 2
Macroglossia 2 2 2 + 2 + + + + 2 +
Short philtrum 2 + + + + + 2 2 2 2 2
Long philtrum + 2 2 2 2 + + + 2 +
Abnormal ears + 2 + 2 2 + + low-set, large ear lobes + 2 2
Cleft palate 2 2 n.r. 2 2 2 2 2 2 2 2
Skeletal anomalies
A/Hypoplasia of
distal phalanges V
+ + + + + Mild Generally short distal
phalanges
Brachymesophalangy
V, generally short
distal phalanges
+ 2 Both 5. toes: distal
phalanx
hypoplastic,
missing middle
phalanx
Short metacarpals/
metatarsals
+ n.r. n.r. 2 2 n.r. n.r. 2 2 2 2
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Table 2. Continued
K2436 K2570 K2437 K2574 K2434 K2441 K2474 K2471 K2445 K2444 K2439
Prominent
interphalangeal
joints
+ + n.r. n.r. + 2 + 2 + 2 2
Prominent distal
phalanges
2 2 2 n.r. + 2 + 2 + 2 2
Sandal gap 2 + 2 n.r. 2 n.r. n.r. n.r. 2 2 2
spinal anomalies 2 n.r. n.r. 2 2 2 n.r. n.r. 2 2 2
Delayed bone age Advanced 2 n.r. +(12 m) 2 n.r. n.r. + (13 m) n.r. n.r. n.r.
Scoliosis 2 + 2 2 2 n.r. n.r. n.r. 2 2 2
Internal anomalies
cryptorchidism Clitoris
hypoplasia
/ / / 2 + 2 Right 2 / 2
CHD PDA 2 2 2(septal
aneurysm
with no shunt)
n.r. 2 2 Slight mitral
insufficiency
2 n.r. 2
Ectodermal anomalies
Body hirsutism + + + + n.r. + + + + + 2
Increased skin
wrinkling
2 2 n.r. + n.r. 2 + 2 + n.r. 2
Fetal finger pads 2 2 n.r. + 2 + + 2 2 n.r. 2
Sparse scalp hair + + 2 2 + Mild n.r. + + + +
Nail a/hypoplasia Bil + left + 2 Mild 2 2 + n.r. 2
2Hands V Bil + Bil + 2 + 2 Short + n.r. 2
2Feet V + + + 2 + 2 Short 2 n.r. 2
Delayed dentition + n.r. +(13 mo) ++ n.r. Abnormal
dentition
("conic"
teeth)
+ n.r. + n.r. n.r.
Brain anomaliies Hippocampal
malrotation
+
Small cerebellum 2 2 2 2 2 2 n.r. 2 2 2 2
Dandy–Walker
anomaly
2 2 2 2 2 2 n.r. 2 2 2 2
Abnormal corpus
callosum
2 2 2 2 2 + n.r. 2 + + 2
Others: Streaky hyperpig-
mentation
Streaky hyperpig-
mentation
n.r. Renal cysts n.r. Umbilical
hernia
n.r. Choroideal cysts in
right and left lateral
ventricle
n.r. n.r. n.r.
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Table 3. Clinical findings of mutation positive CSS patients (part II)
K2432 K2578 K2583 K2443 K2693 K2428 K2438 K2435 K2426 K2442
Gene/mutation ARID1B/
c.5457G.A
ARID1B/
c.6041G.A
ARID1B/
c.6041G.A
ARID1B/
c.6382C.T
ARID1B/
c.6439dupA
ARID1B/
del6q25.3
ARID1B/
del6q25.3
ARID1A/
c.5965C.T
SMARCB1/
c.1121G.A
SMARCE1/
c.218A.C
Age at diagnosis
(month)
96 84 10 48 84 15 72 117 4 30
Gender m m m m m M m m M f
consanguinity in
parents
2 2 n.r. + 2 2 no 2 2 2
Age of mother at
birth (year)
38 29 n.r. 22 25 30 n.r. 29 37 18
Age of father at birth
(year)
41 35 n.r. 24 26 32 n.r. 29 42 47
ID + +++ + + ++ (++) ++ + ++ ++
Sat/walked
independently
(month)]
12/24 9/25 late 24 / 30 10/20 9/34 n.r./31 n.r./.19 n.r./30 18 / 54
First words (month) 48 60 late 36 Absent
speech
None, still babbling 65 12 2 No words, only
vocalization
Hypotonia + + n.r. 2 + + + + 2 2
Seizures (year) 2 2 2 + + 2 2 + + 2
Vision problem refractory
error
2 2 Refraction
error
Divergent
strabismus
2 2 Strabismus + n.r.
Hearing loss 2 2 2 2 2 2 2 2 + n.r.
Frequent infections 2 2 n.r. 2 2 +, sinopulmonary 2 2 + +
Feeding problems n.r. 2 n.r. + 2 (++) + n.r. ++ ++
Behavioural
anomalies
2 +, hyperactivity 2 2 2 2 Rigid
behavior
Hyperactivity Hyperactivity 2
Birth (weeks) 38 39 39 33 40 39 42 38 33 38
Weight (g)/(SD) 2800/21.2 3350/20.3 3200/20.7 1570/21.3 2690/22.1 2900/20.65 3000/21.7 n.r. 1720/20.9 2200/22,3
Length (cm)/
(SD)
n.r. 51/20.4 50/20.8 n.r. n.r. 49/0.23 n.r. n.r. 42/20.9 44 /22,78
OFC (cm/SD) n.r. 31/23.3 35/20.2 n.r. n.r. n.r. n.r. n.r. 30.5/20.4 n.r.
Age at examination
(year)
8 4 10 4 15 1 1
4
17 9 3/4 4 1/4 3 1/4
Height (cm)/(SD) 108/23.8 99/21.4 129/21.8 90/23.6 155,5/0 75/21.62 153.5/23.4 130/21.6 92/23.35 86/23.67
OFC (cm/SD) 53/0.1 51,5/mean 52/20.8 48/22.5 54,5/20.5 42/22.94 57.5/0.8 52.8/20.3 46/23,17 43/24.6
Craniofacial
anomalies
Coarse face + + + + + + + + + +
Low frontal
hairline
+ + + 2 + 2 n.r. + + +
Synophrys 2 2 2 2 2 2 2 2 2 2
Thick eyebrows + + 2 + + 2 + + + +
Long eyelashes + + + + 2 + + + + +
Ptosis + + 2 2 2 2 2 + + +
Narrow palpebral
fissures
2 + 2 2 2 2 2 2 2 2
Flat nasal bridge + + 2 + 2 + 2 + + +
Broad nose + + + + + + (broad nasal tip) 2 + + +
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Table 3. Continued
K2432 K2578 K2583 K2443 K2693 K2428 K2438 K2435 K2426 K2442
Upturned nasal
tip
2 + 2 + + 2 + + 2 2
Thick, anteverted
alae nasi
+ + + + + + + 2 2 +
Large mouth + + + + + + + + + +
Thin upper
vermillion
+ 2 2 2 + 2 2 2 + +
Thick lower
vermillion
+ + + 2 + 2 + + + +
Macroglossia 2 2 2 2 2 2 + + + 2
Short philtrum 2 + 2 2 2 2 2 + 2 +
Long philtrum + 2 2 2 + + 2 2 2 2
Abnormal ears 2 Large + + + + 2 + Small auditory
canal
+
Cleft palate 2 2 2 2 2 2 2 2 2 Suspicion
Skeletal anomalies +
A/Hypoplasia of
distal phalanges
V
+ + + + + + Generally
short distal
phalanges
2 +, 2–4 +
Short
metacarpals/
metatarsals
n.r. 2 2 2 2 IV2V 2 + n.r. n.r.
Prominent
interphalangeal
joints
+ + 2 2 + 2 2 + n.r. n.r.
Prominent distal
phalanges
+ 2 + 2 + 2 2 2 2 2
Sandal gap 2 + + 2 + + 2 + + +
Spinal anomalies 2 2 n.r. 2 n.r. 2 2 2 n.r. n.r.
Delayed bone age + 2 n.r. n.r. n.r. + + ++ +
Scoliosis + 2 2 + 2 2 2 2 + 2
Internal anomalies
Cryptorchidism 2 2 2 + + + 2 + + /
CHD 2 PFO 2 ASD 2 AVSD, secundum
ASD
ASD 2 VSD, ASD,
pulmonic
stenosis
ASD, dextropositio
cordis, slightly
pulmonal
hypertension,
enlarged right
ventricle
Ectodermal
anomalies
Body hirsutism + + + + + 2 + + + n.r.
Increased skin
wrinkling
2 2 + n.r. 2 +, hands 2 2 2 2
Fetal finger pads 2 n.r. + n.r. 2 + 2 2 2 2
Sparse scalp hair + + + + 2 ++ + 2 + +
Nail a/hypoplasia + + + Hypoplasia of
toe nails
+ 2 + + Bil +
2Hands V + 2 + + + (2) + 2 Bil +
2Feet V + + + + + (2) + 2 bil +
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Material, Tables S1 and S2. Clinical photographs are depicted in
Figures 1 and 2 and Supplementary Material, Figures S1–6.
We obtained a written informed consent from the families of
the index individuals for participation in this study. The study
was performed according to the Declaration of Helsinki proto-
cols and was approved by the local institutional review board
(ethical votum 12-5089-BO for CRANIRARE and 08-3663 for
MRNET). Blood samples were collected from the affected indi-
viduals and their parents and DNA was extracted from peripheral
blood lymphocytes by standard extraction procedures.
Exome sequencing
Genomic library preparation
Exome sequencing was performed on DNA from individuals
K2437, K2426, K2442, K2436 and their eight parents and
on DNA from individuals K2434 and K2435 for whom parental
DNA was not available. Exome capture was performed on DNA
from individuals K2434 and K2435 with the NimbleGen SeqCap
EZ Human Exome Library SR KIT (Roche NimbleGen, Waldk-
raiburg, Germany). Five microgram of genomic DNA was frag-
mented by nebulization using a nebulizer device (Invitrogen,
Darmstadt, Germany) following the manufacturer’s instruc-
tions. The fragmented DNA was purified using a QIAquick
PCR Purification column (Qiagen, Hilden, Germany) and quan-
tified on a Nanodrop Photometer. Genomic libraries were pre-
pared using the Illumina Paired End Sample Prep kit following
the manufacturer’s instructions (Illumina, San Diego, CA,
USA), which includes a size selection of DNA fragments in
the size range of 200–400 bp on a 2% agarose gel. Exome en-
richment was performed with 1 mg of the adapter-ligated DNA
sample following the manufacturer’s instructions.
NimbleGen SeqCap EZ Human Exome Library v2.0 was used
to capture the exomes of the samples K2437, K2426, K2442 and
K2436 as described previously (24). Briefly, one microgram
genomic DNA was fragmented by use of a Covaris S220
(CovarisInc, Woburn, MA, USA). Libraries were generated
using the TruSeq Sample Preparation Kit v2 (Illumina) follow-
ing the low-throughput and gel-free method protocols. Sequen-
cing of enriched DNA fragments was performed on an Illumina
HiSeq2000 platform using the paired-end sequencing protocol
with a read length of 101 bp each.
Data analyses
Sequence reads were mapped to the human genome reference as-
sembly GRCh37 (25) using BWA version 0.5.9-r18-dev (26);
PCR duplicates were removed using Picard 1.63; for indel re-
alignment, quality recalibration and variant calling, the
Genome Analysis Toolkit version 1.4-33-g051b450 was used
(27). UnifiedGenotyper was used for both SNP and indel
calling. We obtained in between 3 and 3.5 Gbp of non-duplicate
on-target sequence for each sample captured by use of the
SeqCap EZ Human Exome Library v2.0 resulting in 85% of
the 44 Mbp target sequence covered at least 20-fold. For both
samples captured with the SeqCap EZ Human Exome Library
SR kit, we obtained 0.3 Gbp on target sequence. Variants were
annotated with custom software using the ENSEMBL gene an-
notation track v63 and kept if they were non-synonymous,
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indel, missense, nonsense or in the vicinity of a splice site (within
4 bp of an exon/intron border).
Filtering
We filtered out all variants that occurred in the in-house database
or dbSNP 135 (but not filtering those marked as ‘clinical’, ‘pre-
cious’ or ‘contained in a locus-specific database’) and those oc-
curring in mucin genes. The in-house database contained
exomes of 105 healthy probands, including the eight parents of
individuals K2437, K2426, K2442 and K2436. To identify de
novo mutations, we set the threshold for the variant quality
score (as reported by UnifiedGenotyper) to 200. After filtering,
a total of 201 sequence variations were identified in the
exomes from all six affected individuals. On average, 33 candi-
date genes with a sequence variation were identified per sample.
We reassessed the sequence alterations of four candidate genes
of the SWI/SNF complex by Sanger sequencing and confirmed
the de novo mutations in all of them.
We used PolyPhen (http://genetics.bwh.harvard.edu/pph2/)
to predict the possible impact of missense mutations on the struc-
ture and function of a protein.
Haloplex target enrichment
Libraries of all coding exons and exon–intron boundaries of the
known CSS genesARID1A (NM_006015.4), ARID1B (NM_020
732.3), SMARCA2 (NM_003070.3), SMARCA4 (NM_0011
28849.1), SMARCB1 (NM_003073.3), and SMARCE1 (NM_00
3079.4), as well as the candidate genes ARID2 (NM_15
2641.2), SMARCC1 (NM_003074.3), SMARCC2 (NM_003
075.3), SMARCD1 (NM_003076.4), SMARCD2 (NM_00109
8426.1), SMARCD3 (NM_003078.3), ACTL6A (NM_0043
01.3), ACTL6B (NM_016188.4), PBRM1 (NM_018313.4),
BRD7 (NM_001173984.2), PRMT5 (NM_006109.3), SMARCA1
(NM_003069.3), SMARCA5 (NM_003601.3), HELLS (NM_0180
63.3), CBL (NM_005188.3), C7orf11 (NM_138701) and SHOC2
(NM_007373.3) were prepared from 200 ng of genomic DNA
from 41 index individuals using a customised HaloPlex target en-
richment kit (Agilent technologies, Santa Clara, USA), following
the manufacturer’s protocol. The resulting fragment libraries
were sequenced from both ends (100 bp paired-end sequencing)
using the Illumina HiSeq 2000 running Version3 chemistry (Illu-
mina, San Diego, USA). Candidate genes were chosen according
to structural homology, a functional relationship, or if known to
cause an overlapping phenotype. The total target region size was
188 589 bp.
Validation by Sanger sequencing
Relevant variants were re-sequenced by Sanger sequencing. The
affected exons of ARID1B, SMARCA2, SMARCB1, SMARCD2,
SMARCC1, CBL, PHF6 andARID1Awere amplified from DNA
of the affected individuals and—if available—their parents by
PCR, performed according to the standard procedures, and
were sequenced using the BigDye Terminator method on an
ABI 3010xl or ABI 3100 sequencer. Sequencing data were ana-
lyzed using the Geneious Pro (5.6.4.) software (Biomatters Ltd,
New Zealand) or the FinchTV software (Geospiza, Seattle,
USA). All primers for amplification and sequencing were
selected with ExonPrimer and were ordered from Biomers
(Ulm, Germany) or IDT (Leuven, Belgium; primer sequences
are available on request).
Molecular karyotyping
A genome-wide copy number microarray analysis was per-
formed using the Affymetrix 6.0 SNP array in individual
K2438 and the CytoScanHD array in individual K2428 (Affy-
metrix, Santa Clara, CA, USA) according to the manufacturer’s
instructions. Data analysis was carried out using the Affymetrix
Chromosome Analyse Suite (ChAS v1.2 or v2.0), and the data
interpretation was based on the February 2009 human genome
sequence assembly (GRCh37/hg19). Conspicuous regions
were compared with known CNVs, as provided by the Database
of Genomic Variants (http://projects.tcag.ca/variation/). Par-
ticular attention was paid to the genes that code for known com-
ponents of the SWI/SNF complex.
Quantitative real-time PCR
The presence of the ARID1B-intragenic deletion in individual
K2438 was confirmed by a quantitative real-time PCR assay
using the Roche Universal ProbeLibrary System. Part of exon
7 of ARID1B (chr6:157454217-157454286) was amplified with
primers ARID1B_left: 5′-GACAGGACCATCCATGTCG-3′
and ARID1B_right: 5′-CTGAAAGCTACTGATTCCAGCA-3′,
and detected with the universal probe 2. As an internal control,
an assay for the AS-SRO on chromosome 15 was used (28). The
analysis was performed on the LightCycler 480 (Roche).
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